Michael Thomas Heffernan's Net Worth
$40 Million
Who is Michael Thomas Heffernan?
Michael Thomas Heffernan has an estimated net worth of $40 Million. This is based on reported shares across multiple companies, which include COLLEGIUM PHARMACEUTICAL, INC, Biohaven Pharmaceutical Holding Co Ltd., Trevi Therapeutics, Inc., SYNLOGIC, INC., Akebia Therapeutics, Inc., Biohaven Ltd., Ocata Therapeutics, Inc., CORNERSTONE THERAPEUTICS INC, and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Michael Thomas Heffernan's CIK is 0001448914
Past Insider Trading and Trends
2022 was Michael Thomas Heffernan's most active year for acquiring shares with 26 total transactions. Michael Thomas Heffernan's most active month to acquire stocks was the month of November. 2022 was Michael Thomas Heffernan's most active year for disposing of shares, totalling 31 transactions. Michael Thomas Heffernan's most active month to dispose stocks was the month of November. 2020 saw Michael Thomas Heffernan paying a total of $1,578,402.99 for 445,815 shares, this is the most they've acquired in one year. In 2020 Michael Thomas Heffernan cashed out on 627,474 shares for a total of $7,678,811.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26
Chairman, President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.34% | 7.69K |
—
|
—
| 45.51K |
May 16
| |||
Form 4
| +34.94% | 9.79K |
—
|
—
| 37.81K |
May 18
| |||
Form 4
|
—
|
0
|
$19.86 | -$186,038.90 | 28.02K |
Scheduled
|
Dec 22 - Dec 27
| ||
Form 4
|
—
|
0
|
$19.62 | -$583,124.28 | 28.02K |
Scheduled
|
Dec 19 - Dec 21
| ||
Form 4
|
—
|
0
|
$18.62 | -$1,334,765.44 | 28.02K |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
| +100.34% | 14.04K |
—
|
—
| 28.02K |
May 19
| |||
Form 4
| +245.64% | 9.94K |
—
|
—
| 13.99K |
May 20
| |||
Form 4
| -92.52% | -50.08K |
$25.30 | -$1,266,773.72 | 4.05K |
Scheduled
|
Mar 15
| ||
Form 4
| -19.45% | -13.07K |
$19.13 | -$250,048.23 | 54.12K |
Scheduled
|
Aug 11
| ||
Form 4
| -17.85% | -14.60K |
$22.05 | -$411,232.50 | 67.19K |
May 20
| |||
Form 4
| -19.05% | -19.25K |
$21.63 | -$416,421.29 | 81.8K |
Scheduled
|
May 13
| ||
Form 4
| -4.68% | -4.96K |
$21.62 | -$107,278.44 | 101.05K |
Feb 10
| |||
Form 4
| -16.28% | -20.61K |
$13.83 | -$4,915,427.81 | 106.01K |
Scheduled
|
Jan 21
| ||
Form 4
| -3.64% | -4.78K |
$11.24 | -$53,715.96 | 126.62K |
Aug 9
| |||
Form 4
| -0.51% | -667.00 |
$10.35 | -$6,903.45 | 131.4K |
Jul 19
| |||
Form 4
| -15.92% | -25.00K |
$11.26 | -$281,500.00 | 132.07K |
Scheduled
|
Jul 15
| ||
Form 4
| -13.73% | -25.00K |
$11.37 | -$284,245.54 | 157.07K |
Scheduled
|
Jun 17
| ||
Form 4
| -12.07% | -25.00K |
$12.84 | -$321,041.63 | 182.07K |
Scheduled
|
May 15
| ||
Form 4
| +2.33% | 4.71K |
—
|
—
| 207.07K |
Apr 25
| |||
Form 4
| -11.00% | -25.00K |
$15.09 | -$377,365.68 | 202.36K |
Scheduled
|
Apr 15
| ||
Form 4
| -9.91% | -25.00K |
$17.17 | -$429,250.00 | 227.36K |
Scheduled
|
Mar 15
| ||
Form 4
| -9.01% | -25.00K |
$14.81 | -$370,223.80 | 252.36K |
Scheduled
|
Feb 15
| ||
Form 4
| -2.75% | -7.85K |
$14.39 | -$112,975.89 | 277.36K |
Feb 8
| |||
Form 4
| -0.28% | -787.00 |
$15.76 | -$12,403.12 | 285.21K |
Jan 18
| |||
Form 4
| -8.04% | -25.00K |
$15.56 | -$389,000.00 | 286K |
Scheduled
|
Jan 15
| ||
Form 4
| -7.44% | -25.00K |
$18.18 | -$454,490.85 | 311K |
Scheduled
|
Dec 17
| ||
Form 4
| -6.93% | -25.00K |
$16.60 | -$415,122.00 | 336K |
Scheduled
|
Nov 15
| ||
Form 4
| -6.48% | -25.00K |
$16.53 | -$413,250.00 | 361K |
Scheduled
|
Oct 15
| ||
Form 4
| -0.52% | -2.02K |
$18.03 | -$36,510.75 | 386K |
Aug 23
| |||
Form 4
| -0.17% | -668.00 |
$20.15 | -$13,460.20 | 388.02K |
Aug 3
| |||
Form 4
| -27.85% | -150.00K |
$25.27 | -$3,790,938.86 | 388.69K |
Jun 11 - Jun 12
| |||
Form 4
| -1.30% | -7.10K |
$26.21 | -$186,100.00 | 538.69K |
Scheduled
|
May 10
| ||
Form 4
| -7.52% | -44.40K |
$26.00 | -$1,154,401.00 | 545.79K |
Scheduled
|
Apr 19
| ||
Form 4
| -0.68% | -4.05K |
$21.77 | -$88,168.50 | 590.19K |
Feb 26
| |||
Form 4
| -0.13% | -788.00 |
$23.38 | -$18,423.44 | 594.24K |
Feb 5
| |||
Form 4
| +14.65% | 76.04K |
$10.17 | $10,617.48 | 595.03K |
Jan 25 - Jan 26
| |||
Form 4
| -1.86% | -20.00K |
$25.01 | -$500,164.08 | 1.05M |
Scheduled
|
Jan 22 - Jan 23
| ||
Form 4
| -3.58% | -20.00K |
$22.50 | -$450,000.00 | 538.99K |
Scheduled
|
Jan 19
| ||
Form 4
| -8.21% | -50.00K |
$15.53 | -$776,500.00 | 558.99K |
Scheduled
|
Nov 15
| ||
Form 4
| -0.02% | -96.00 |
$11.50 | -$2,335.04 | 608.99K |
Jul 28 - Aug 4
| |||
Form 4
| -0.24% | -1.47K |
$14.95 | -$22,006.40 | 609.08K |
Mar 17
| |||
Form 4
| +9.90% | 55K |
—
|
—
| 610.55K |
Feb 10
| |||
Form 4
| +0.77% | 4.25K |
$3.28 | $13,935.36 | 555.55K |
Jan 27 - Jan 31
| |||
Form 4
| +0.22% | 1.21K |
$10.31 | $12,495.72 | 551.3K |
Jul 29
| |||
Form 4
| +3.64% | 13.6K |
$2.49 | $33,904.51 | 387.05K |
Apr 5
| |||
Form 4
| +5.10% | 18.14K |
—
|
—
| 373.44K |
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Pharmaceutical Holding Co Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 31 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $1.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 6.35K |
$10.00 |
—
| 6.35K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNLOGIC, INC. (SYBX) Snapshot price: $3.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.27% | 13.7K |
—
|
—
| 48.59K |
Jun 2
| |||
Form 4
| +64.67% | 13.7K |
—
|
—
| 34.89K |
Jun 5
| |||
Form 4
| +183.01% | 13.7K |
—
|
—
| 21.19K |
Jun 6
| |||
Form 4
|
∞
| 7.49K |
—
|
—
| 7.49K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||